Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose oxytocin for augmentation of delayed labour
2012-000356-33Phase 4Terminated
- Sponsor
- Region Västra Götaland
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxytocin in labor dystocia (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Caesarean delivery rate. Started Jan 2013; status: terminated.
02
Drugs
oxytocin
03
Conditions
labor dystocia
Beyond the preview
Go deeper on 2012-000356-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000356-33.